We are so proud and happy to inform you that BioReperia is a part of an international consortium of 10 partners that has been granted support by the European Union in the H2020-MSCA-RISE program.
The consortium, consisting of 5 academic partners and 5 non-academic partners, will focus on multi-disciplinary approaches and knowledge exchange in the area of inflammation and disease, and BioReperia will develop important partnerships and cutting-edge knowledge related to how the immune system in general and cysteine leukotriene signaling in particular contribute to cancer development, through the use of our innovative zebrafish patient-derived xenograft models.
We are extremely excited and look forward to 4-years of inspiring and important work in this area.
